Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

NephU Podcast
19/08/2024 16 min
Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Listen "Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials"

Descargar episodio Ver en sitio original

Episode Synopsis

The goal of this webinar is to discuss the evidence that supports proteinuria reduction as a surrogate marker in IgA Nephropathy clinical trials.

More episodes of the podcast NephU Podcast

US.CORP.X.25.00181 NephU 4-Hit Process in IgAN – The Role of APRIL podcast snippet 09/09/2025
US.CORP.X.25.00144 NephU Dialysis Quality Care and 2 yr results of KCC Model Audio recording 28/07/2025
US.CORP.X.25.00124 NephU Importance of Hematuria as a Biomarker for IgA Nephropathy 02/07/2025
US.CORP.X.25.00096 NephU Update in Xenotransplantation & Confirmation of the new Admin for CMS 04/06/2025
US.CORP.X.25.00068 NephU Hot Topics in Nephrology- Updates on the Federal Nomination Audio 29/04/2025
US.CORP.X.25.00040 NephU Hot Topics Potential Cuts to National Institutes of Health on Medical Research Fees 25/04/2025
US.CORP.X.25.00013 NephU Research Insights and Clinical Translation Recording 10/04/2025
US.CORP.V.25.00005 NephU Updates in Ketogenic Diet for Polycystic Kidney Disease Recording 20/03/2025
US.CORP.X.25.00030 NephU Understanding the Benefits and Risks of Corticosteroid Recording 13/03/2025
US.CORP.X.25.00020 NephU The Latest Xenotransplantation Patient and Thoughts Audio Recording 20/02/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA